NCT06513507Active, not recruiting
A Clinical Study to Assess the Efficacy of Cannabigerol in Patients with Active Rheumatoid Arthritis.
Source: ClinicalTrials.gov · Last updated 21 Nov 2024
Brief summary (registry, in English)
This is a single-group exploratory longitudinal prospective study lasting 8 weeks. The study aims to measure the efficacy of purified cannabigerol (CBG) in patients with active rheumatoid arthritis using laboratory and self-reported outcome measures.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 12 (actual)
- First submitted
- 17 Jul 2024
- Start date
- 3 Jun 2024
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Raphael Pharma
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT06513507
What you commit to
- Study type: Interventional
- Participants enrolled: 12
- From 3 Jun 2024 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Recent invasive medical procedure or surgery
- Use of cytochrome P450 or 3A4 inhibitors
Other illness
- Pre-existing chronic conditions preventing adherence
- Severe allergic reactions requiring an Epi-pen
- Active malignancy or ongoing oncology treatment
- History of substance abuse
Other
- Use of opiates in the last 4 weeks or cannabis in the last 8 weeks
- Pregnant or breastfeeding women
Who the study is looking for
- Male or female, over 25 years of age
- Positive anti-CCP blood test
- Active RA-related inflammation with at least 2 swollen joints
- University graduate
- Generally healthy with no uncontrolled chronic disease
- Able to read, understand, and sign informed consent
- Resides in the USA
- Willing to comply with study requirements and avoid other cannabis products during the study period
Age in the registry: 25 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Citruslabs Coordinator of this site? Confirm its status | Santa Monica | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.